Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
[18F]F-RESCA-RT4
DRUG
3 trials
Sponsors
RenJi Hospital
Conditions
Bladder Cancer
Breast Cancer
Breast Cancer Metastatic
Breast Neoplasms
Cervical Cancer
Cholangiocarcinoma
Endometrial Cancer
Head and Neck Cancer
+13 more
Phase 1
Target-specific immunoPET Imaging of Breast Cancer
Recruiting
NCT06715826
RenJi Hospital
Breast Cancer, Breast Cancer Metastatic, Breast Neoplasms
Start: 2024-09-21
End: 2026-11-01
Target: 200
Updated: 2026-01-27
Phase 2
Trop2-targeted immunoPET Imaging of Solid Tumors
Recruiting
NCT06851663
RenJi Hospital
Bladder Cancer, Cervical Cancer, Cholangiocarcinoma +11
Start: 2024-12-23
End: 2027-12-01
Target: 400
Updated: 2026-05-29
Unknown Phase
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Recruiting
NCT07026110
RenJi Hospital
Lung Cancer, Lung Cancer Metastatic, Lung Diseases +2
Start: 2024-12-23
End: 2026-10-31
Target: 100
Updated: 2025-06-18
Related Papers
Immuno-PET/CT Imaging of Trop2 Expression with [<sup>18</sup>F]AlF-RESCA-RT4 Enhances Diagnosis of Breast Cancers and the Metastases.
2026-05-14
Trop2 immuno-PET/CT imaging of prostate cancer: a proof-of-concept translational study.
2025-12-31